Immunology & Infectious Diseases

Peter WalzerPeter Walzer, MD, MSc

Int Med-Infect Disease

Professor

Research Summary

Dr. Walzer is Associate Chairman for Research in the Department of Internal Medicine and ACOS for Research at the VA Medical Center. He has long been recognized internationally as a leader in P. carinii research. His studies have mainly focused on immunopathogenesis and therapy of the infection. He is board certified in Internal Medicine and Infectious Diseases, and has been elected to membership in the American College of Physicians, Infectious Disease Society of America (Fellow), American Federation for Clinical Research, Central Society for Clinical Research, American Society for Microbiology, American Association for the Advancement of Science, American Society for Tropical Medicine and Hygiene, American Society for Parasitologists, American Thoracic Society, Society for Experimental Biology and Medicine, American Association of Immunologists and Sigma Xi. Dr. Walzer was awarded the Faculty Achievement Award from the University of Cincinnati in 1997. His published works include approximately 115 original publications, three books, 70 chapters, reviews, editorials and letters and 105 abstracts and presented papers.

Recent Publications

Tiriprneni, R., Daly, K.R., Jarlsbert, L.G., Koch, J.V., Swartzman, A., Roth, B., Walzer, P.D., Huang, L.  Health care worker occupation is associated with immune response to Pneumocystis. Emerg Infect Dis (in press).

Nkinin, S.W., Ndzi, E., Asongany, T., Daly, K., Koch, J., Walzer, P.D., Kaneshiro, E.S.  Detection of Pneumocystis jirovecii antibodies in sera from Cameroonians by ELISA using recombinant MSG fragments.  Meta Tropica (in press).

Cushion MT, Walzer PD. Preclinical drug discovery for new anti-pneumocystiscompounds. Curr Med Chem. 2009;16(20):2514-30. PubMed PMID: 19601796.

Daly K, Koch J, Respaldiza N, de la Horra C, Montes-Cano MA, Medrano FJ,Varela JM, Calderon EJ, Walzer PD. Geographical variation in serologicalresponses to recombinant Pneumocystis jirovecii major surface glycoproteinantigens. Clin Microbiol Infect. 2009 Mar 21. [Epub ahead of print] PubMed PMID: 19416292. 

Linke MJ, Ashbaugh AA, Koch JV, Levin L, Tanaka R, Walzer PD. Effects ofsurfactant protein-A on the interaction of Pneumocystis murina with its host atdifferent stages of the infection in mice. J Eukaryot Microbiol. 2009Jan-Feb;56(1):58-65. PubMed PMID: 19335775; PubMed Central PMCID: PMC2675919.

Walzer PD, Djawe K, Levin L, Daly KR, Koch J, Kingsley L, Witt M, Golub ET,Bream JH, Taiwo B, Morris A. Long-term serologic responses to the Pneumocystisjirovecii major surface glycoprotein in HIV-positive individuals with and withoutP. jirovecii infection. J Infect Dis. 2009 May 1;199(9):1335-44. PubMed PMID:19301979; PubMed Central PMCID: PMC2714884.

"));